Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 1
1995 46
1996 127
1997 170
1998 323
1999 441
2000 577
2001 537
2002 480
2003 466
2004 493
2005 480
2006 416
2007 446
2008 448
2009 349
2010 320
2011 269
2012 244
2013 244
2014 222
2015 180
2016 145
2017 146
2018 118
2019 74
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

7,451 results
Results by year
Filters applied: . Clear all
Page 1
Bictegravir: First Global Approval.
Markham A. Markham A. Drugs. 2018 Apr;78(5):601-606. doi: 10.1007/s40265-018-0896-4. Drugs. 2018. PMID: 29564777 Review.
A review of the toxicity of HIV medications.
Margolis AM, Heverling H, Pham PA, Stolbach A. Margolis AM, et al. J Med Toxicol. 2014 Mar;10(1):26-39. doi: 10.1007/s13181-013-0325-8. J Med Toxicol. 2014. PMID: 23963694 Free PMC article. Review.
Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom.
Pedersen OS, Pedersen EB. Pedersen OS, et al. Antivir Chem Chemother. 1999 Nov;10(6):285-314. doi: 10.1177/095632029901000601. Antivir Chem Chemother. 1999. PMID: 10628805 Review.
Understanding the reverse transcriptase inhibitors in HIV.
Edmonds-Ogbuokiri J. Edmonds-Ogbuokiri J. Fac Notes (New Orleans La). 1998 Nov-Dec;10(6):13-5. Fac Notes (New Orleans La). 1998. PMID: 11366142
The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients.
Di Biagio A, Ricci E, Viscoli C, Mesini A, Menzaghi B, Carenzi L, Orofino G, Parruti G, Martinelli C, Madeddu G, De Socio GV, Franzetti M, Quirino T, Bonfanti P; CISAI Group. Di Biagio A, et al. Curr HIV Res. 2013 Apr;11(3):179-86. doi: 10.2174/1570162x113119990036. Curr HIV Res. 2013. PMID: 23432466 Clinical Trial.
7,451 results
Jump to page
Feedback